David Hallal, Scholar Rock CEO, joins 'Fast Money' to talk its recent drug study results that found its drug taken in ...

View the latest Scholar Rock Holding Corp. (SRRK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...

FLAT ROCK, MI — Flat Rock Community Schools announced the top 10 graduates in the Flat Rock High School Class of 2025. The ...

We recently published a list of These 10 Stocks Boast Double-Digit Gains Amid Boring Market. Scholar Rock Holding Corporation ...

Shares of Scholar Rock Holding (NASDAQ: SRRK) are soaring today, up 13.7% as of 1:14 p.m. ET. The move comes as the S&P 500 ...

Shares of Scholar Rock Holdings jumped Wednesday after the biopharmaceutical firm reported positive results from a ...

Scholar Rock is preparing for the PDUFA date on September 22 for apitegromab, which could set a new standard of care for SMA. The company is financially stable, with a cash runway into early 2027, a ...

An unknown assailant in Washington D.C. attacked a gay man with a rock, causing him to bleed profusely. The victim suspects his attacker may be a young local teen who has yelled homophobic slurs ...